comparemela.com

Latest Breaking News On - Pharm yarok - Page 1 : comparemela.com

IM Cannabis : Management s Discussion and Analysis Q2 2023

IM Cannabis Corp. Management s Discussion and Analysis For the Three and Six Months Ended June 30, 2023 August 14,. -Today at 10:29 am- MarketScreener

United statesH efaUnited kingdomVironna pharmPharm yarokAdjupharm gmbhI mc farms israel ltdRosen high way ltdInternational financial reporting standardsOranim plus pharm ltdI mc pharma ltdCanadian securities exchangeTrichome financial corpRa yarok pharm ltdHerbs ltdIm cannabis corp

IM Cannabis Q1 Revenue Increases 18% Sequentially to $23 6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational. #imcannabis #IMCHoldings #imcc

Israel generalUnited statesVironna pharmOren shusterSde avrahamAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdIsraeli medical cannabis agencyCompany expects to achieve positive adjustedPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corp

IM Cannabis Q4 Revenue Increases 35% Sequentially to C$20 Million

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook. Fiscal Year 2021 revenues increased 242%. #imcannabis #imc #imcc

Israel generalUnited statesOranim pharmOren shusterAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdOntario cannabisIsraeli medical cannabis agencyPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corpRa yarok pharm ltd

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

/PRNewswire/ IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis.

Israel generalUnited statesState of israelOranim pharmOren shusterAdjupharm gmbhMaya lustigPharm yarokHerbs ltdRosen high way ltdIsraeli medical cannabis agencyCompany contactWhile the companyPanaxia labs israel ltdNutraceuticals incPrnewswire im cannabis corp

IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel

/PRNewswire/ IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company.

United statesOren shusterAdjupharm gmbhMaya lustigPharm yarokRosen high way ltdHerbs ltdCompany contactSource im cannabis corpHigh way shinua ltdCompany onPanaxia labs israel ltdCanadian securities exchangePrnewswire im cannabis corpI mc pharma ltdIm cannabis corp

vimarsana © 2020. All Rights Reserved.